These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 38741795)
21. Natural history and impact of treatment with tafamidis on major cardiovascular outcome-free survival time in a cohort of patients with transthyretin amyloidosis. Bézard M; Kharoubi M; Galat A; Poullot E; Guendouz S; Fanen P; Funalot B; Moktefi A; Lefaucheur JP; Abulizi M; Deux JF; Gendre T; Audard V; El Karoui K; Canoui-Poitrine F; Zaroui A; Itti E; Teiger E; Planté-Bordeneuve V; Oghina S; Damy T Eur J Heart Fail; 2021 Feb; 23(2):264-274. PubMed ID: 33094885 [TBL] [Abstract][Full Text] [Related]
22. Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis. Treglia G; Glaudemans AWJM; Bertagna F; Hazenberg BPC; Erba PA; Giubbini R; Ceriani L; Prior JO; Giovanella L; Slart RHJA Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1945-1955. PubMed ID: 29687207 [TBL] [Abstract][Full Text] [Related]
23. Myocardial Scintigraphy in Diagnosing Cardiac Transthyretin Amyloidosis. Petrovic M; Lopez PD; Eng C; Rashid M Tex Heart Inst J; 2022 Jul; 49(4):. PubMed ID: 36006616 [TBL] [Abstract][Full Text] [Related]
24. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis. Castano A; Haq M; Narotsky DL; Goldsmith J; Weinberg RL; Morgenstern R; Pozniakoff T; Ruberg FL; Miller EJ; Berk JL; Dispenzieri A; Grogan M; Johnson G; Bokhari S; Maurer MS JAMA Cardiol; 2016 Nov; 1(8):880-889. PubMed ID: 27557400 [TBL] [Abstract][Full Text] [Related]
25. The Role of Imaging in Diagnosing Transthyretin Cardiac Amyloidosis. Chaaban N; Kshatriya S Cureus; 2021 Jun; 13(6):e15468. PubMed ID: 34262806 [TBL] [Abstract][Full Text] [Related]
26. A case of cardiac amyloidosis in an elderly Japanese patient with amyloidogenic transthyretin Val122Ile variant. Ono R; Takahashi H; Sato T; Yamazaki T; Hori Y; Fukushima K J Cardiol Cases; 2020 Nov; 22(5):221-225. PubMed ID: 33133314 [TBL] [Abstract][Full Text] [Related]
27. Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy. Paton DM Drugs Today (Barc); 2019 Dec; 55(12):727-734. PubMed ID: 31942875 [TBL] [Abstract][Full Text] [Related]
28. Conduction abnormalities and role of cardiac pacing in cardiac amyloidosis: A systematic review. Alreshq R; Tugal D; Siddiqi O; Ruberg F Pacing Clin Electrophysiol; 2021 Dec; 44(12):2092-2099. PubMed ID: 34632598 [TBL] [Abstract][Full Text] [Related]
33. Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid. Hutt DF; Fontana M; Burniston M; Quigley AM; Petrie A; Ross JC; Page J; Martinez-Naharro A; Wechalekar AD; Lachmann HJ; Quarta CC; Rezk T; Mahmood S; Sachchithanantham S; Youngstein T; Whelan CJ; Lane T; Gilbertson JA; Rowczenio D; Hawkins PN; Gillmore JD Eur Heart J Cardiovasc Imaging; 2017 Dec; 18(12):1344-1350. PubMed ID: 28159995 [TBL] [Abstract][Full Text] [Related]
34. The Association of Cardiac Biomarkers, the Intensity of Tc99 Pyrophosphate Uptake, and Survival in Patients Evaluated for Transthyretin Cardiac Amyloidosis in the Early Therapeutics Era. Martyn T; Saef J; Hussain M; Ives L; Kiang A; Estep JD; Collier P; Starling RC; Cremer PC; Tang WHW; Hanna M; Jaber WA J Card Fail; 2022 Oct; 28(10):1509-1518. PubMed ID: 35843490 [TBL] [Abstract][Full Text] [Related]
35. Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner. Gertz M; Adams D; Ando Y; Beirão JM; Bokhari S; Coelho T; Comenzo RL; Damy T; Dorbala S; Drachman BM; Fontana M; Gillmore JD; Grogan M; Hawkins PN; Lousada I; Kristen AV; Ruberg FL; Suhr OB; Maurer MS; Nativi-Nicolau J; Quarta CC; Rapezzi C; Witteles R; Merlini G BMC Fam Pract; 2020 Sep; 21(1):198. PubMed ID: 32967612 [TBL] [Abstract][Full Text] [Related]
36. Diagnostic performance characteristics of planar quantitative and semi-quantitative parameters of Tc Pandey S; Teruya S; Rodriguez C; Deluca A; Kinkhabwala M; Johnson LL; Fine D; Sabogal N; Winburn M; Castillo M; Bhatia K; Malkovskaya R; Raiszadeh F; Kurian D; Miller EJ; Einstein AJ; Maurer MS; Ruberg FL J Nucl Cardiol; 2023 Aug; 30(4):1414-1419. PubMed ID: 36823486 [TBL] [Abstract][Full Text] [Related]
37. Illustrative review of cardiac amyloidosis by multimodality imaging. Tanaka H Heart Fail Rev; 2023 Jan; 28(1):113-122. PubMed ID: 35474404 [TBL] [Abstract][Full Text] [Related]
38. Modeling the Cost and Health Impacts of Diagnostic Strategies in Patients with Suspected Transthyretin Cardiac Amyloidosis. Ge Y; Pandya A; Cuddy SAM; Singh A; Singh A; Dorbala S J Am Heart Assoc; 2022 Sep; 11(18):e026308. PubMed ID: 36102240 [TBL] [Abstract][Full Text] [Related]
39. Transthyretin Cardiac Amyloidosis: An Evolution in Diagnosis and Management of an "Old" Disease. Smiley DA; Rodriguez CM; Maurer MS Cardiol Clin; 2022 Nov; 40(4):541-558. PubMed ID: 36210137 [TBL] [Abstract][Full Text] [Related]